[Female pseudohermaphroditism of therapeutic origin. Apropos of a case].
D000014:Abnormalities, Drug-Induced; D000728:Androgens / Q000009:adverse effects; D000818:Animals; D003270:Contraceptive Agents / Q000009:adverse effects; D012734:Disorders of Sex Development / Q000139:chemically induced* / Q000175:diagnosis; D004967:Estrogens / Q000009:adverse effects; D005003:Ethisterone / Q000009:adverse effects; D005260:Female; D005315:Fetal Diseases / Q000139:chemically induced; D005836:Genitalia, Female / Q000002:abnormalities / Q000196:embryology; D006728:Hormones / Q000008:administration & dosage; D006801:Humans; D006965:Hyperplasia / Q000151:congenital; D008297:Male; D009277:Nandrolone / Q000009:adverse effects; D010051:Ovarian Neoplasms / Q000150:complications; D011247:Pregnancy; D011248:Pregnancy Complications; D011270:Pregnancy, Animal; D011374:Progesterone / Q000009:adverse effects; D011372:Progestins / Q000009:adverse effects* / Q000378:metabolism; D051381:Rats; D012728:Sex Chromatin; D012732:Sex Determination Analysis; D013739:Testosterone / Q000009:adverse effects
D000728:Androgens; D003270:Contraceptive Agents; D004967:Estrogens; D006728:Hormones; D011372:Progestins; D013739:Testosterone; D011374:Progesterone; D009277:Nandrolone; D005003:Ethisterone
Pseudo-hermaphrodisme féminin d'origine thérapeutique. A propos d'une observation.